Showing results (311-320 of 356) with videos related to
Sort By:
Pageof 36
The Oncologist|March 31, 2025
A pilot survey into the landscape of neuro-oncology care in the communityChristine Lu-Emerson, Sajeel Chowdhary, Rupesh Kotecha, et al.Neurology. Clinical Practice|September 6, 2021
Treatment of Dementia With Bosutinib: An Open-Label Study of a Tyrosine Kinase InhibitorKennedy D Mahdavi, Sheldon E Jordan, Hannah R Barrows, et al.International Journal of Molecular Sciences|February 13, 2026
Targeting Pediatric Glioblastomas by Combining OLIG2 Inhibitor CT-179 with Fractionated Radiation in a Panel of Patient-Derived Orthotopic Xenograft Mouse ModelsHolly Lindsay, Yuchen Du, Lin Qi, et al.Journal of Neuro-Oncology|October 29, 2015
A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group studyH Ian Robins, Peixin Zhang, Mark R Gilbert, et al.International Journal of Radiation Oncology, Biology, Physics|June 3, 2008
A pilot safety study of lenalidomide and radiotherapy for patients with newly diagnosed glioblastoma multiformeJan Drappatz, Eric T Wong, David Schiff, et al.Neuro-Oncology|April 25, 2007
Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adultsSantosh Kesari, David Schiff, Lisa Doherty, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumorsIan Krop, Tim Demuth, Tina Guthrie, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|August 22, 2012
Multicolored stain-free histopathology with coherent Raman imagingChristian W Freudiger, Rolf Pfannl, Daniel A Orringer, et al.Journal of Translational Medicine|October 22, 2024
Low PD-L1 expression, MAP2K2 alterations, and enriched HPV gene signatures characterize brain metastases in head and neck squamous cell carcinomaMichael J Dennis, Dean C Pavlick, Alec Kacew, et al.Journal of Experimental & Clinical Cancer Research : CR|December 14, 2022
Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed Glioblastoma patients: safety and efficacy assessmentDaniela A Bota, Thomas H Taylor, David E Piccioni, et al.Pageof 36